Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.460
-0.020 (-0.57%)
At close: Sep 12, 2025, 4:00 PM EDT
3.410
-0.050 (-1.45%)
After-hours: Sep 12, 2025, 6:19 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.21 billion as of September 12, 2025. Its market cap has decreased by -5.98% in one year.
Market Cap
1.21B
Enterprise Value
1.34B
1-Year Change
-5.98%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.21B, an increase of 230.58%. That is a compound annual growth rate of 8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.21B | -19.68% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |